ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
The purpose of the study is to assess the safety and efficacy of targeted intramyocardial delivery of Auto-CD34+ cells for increasing exercise time and amelioration of anginal symptoms in subjects with refractory angina and chronic myocardial ischemia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE#824939
- A Clinical Evaluation of AMJ-401#905132
- The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection#1133774
- Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration#910203
- Barriers to Optimization of Medical Therapy and the Role of Checklist-Based Decision Support in Heart Failure.#338620
Record · ID 876993
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive